Ning Y - Search Results

1

miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.

Liu L, Ning Y, Yi J, Yuan J, Fang W, Lin Z, Zeng Z. Liu L, et al. Among authors: ning y. Biomed Pharmacother. 2020 May;125:109865. doi: 10.1016/j.biopha.2020.109865. Epub 2020 Feb 12. Biomed Pharmacother. 2020. PMID: 32058212 Free article.

2

Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.

Deng Y, Zhao F, Hui L, Li X, Zhang D, Lin W, Chen Z, Ning Y. Deng Y, et al. Among authors: ning y. J Ovarian Res. 2017 Jul 25;10(1):50. doi: 10.1186/s13048-017-0333-4. J Ovarian Res. 2017. PMID: 28743276 Free PMC article.

3

Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.

Ning Y, Cui Y, Li X, Cao X, Chen A, Xu C, Cao J, Luo X. Ning Y, et al. Biomed Pharmacother. 2018 Jul;103:262-271. doi: 10.1016/j.biopha.2018.04.022. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29656182

4

FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

Liu L, Yi J, Yuan J, Yao T, Lin Z, Ning Y, Zeng Z. Liu L, et al. Among authors: ning y. Cancer Biomark. 2020;28(1):1-8. doi: 10.3233/CBM-182119. Cancer Biomark. 2020. PMID: 32224523

5

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Ning Y, Zeng Z, Deng Y, Feng W, Huang L, Liu H, Lin J, Zhang C, Fan Y, Liu L. Ning Y, et al. Cancer Sci. 2021 May;112(5):1785-1797. doi: 10.1111/cas.14864. Epub 2021 Mar 31. Cancer Sci. 2021. PMID: 33788346 Free PMC article.

6

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

Deng Y, Liu L, Feng W, Lin Z, Ning Y, Luo X. Deng Y, et al. Among authors: ning y. Recent Pat Anticancer Drug Discov. 2021;16(4):533-539. doi: 10.2174/1574891X16666210706153740. Recent Pat Anticancer Drug Discov. 2021. PMID: 34551701

7

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.

Liu L, Lv J, Lin Z, Ning Y, Li J, Liu P, Chen C. Liu L, et al. Among authors: ning y. Front Mol Biosci. 2022 Feb 9;8:785922. doi: 10.3389/fmolb.2021.785922. eCollection 2021. Front Mol Biosci. 2022. PMID: 35223984 Free PMC article.

8

Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5.

Xu L, Wang L, Gan Y, Lin J, Ning S, Deng J, Ning Y, Feng W. Xu L, et al. Among authors: ning s, ning y. Aging (Albany NY). 2024 Jul 26;16(14):11275-11288. doi: 10.18632/aging.205991. Epub 2024 Jul 26. Aging (Albany NY). 2024. PMID: 39068672 Free PMC article.

9

Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells.

Ning Y, Li Q, Xiang H, Liu F, Cao J. Ning Y, et al. Oncol Rep. 2012 Jun;27(6):1857-64. doi: 10.3892/or.2012.1739. Epub 2012 Mar 22. Oncol Rep. 2012. PMID: 22447287

10

7-difluoromethoxyl-5,4'-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1.

Ning YX, Li QX, Ren KQ, Quan MF, Cao JG. Ning YX, et al. Oncol Lett. 2014 Jul;8(1):295-300. doi: 10.3892/ol.2014.2080. Epub 2014 Apr 22. Oncol Lett. 2014. PMID: 24959264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,035 results

Search Page

Filters